ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,636, issued on July 1, was assigned to SK BIOSCIENCE Co. LTD. (Seongnam-si, South Korea).
"Respiratory syncytial virus recombinant F protein and vaccine composition containing same" was invented by Eun-som Kim (Seongnam-si, South Korea), Teawoo Kwon (Seongnam-si, South Korea), Ki-weon Seo (Seongnam-si, South Korea), Seung-hye Hong (Seongnam-si, South Korea), Su Jeen Lee (Seongnam-si, South Korea), Dong Soo Ham (Seongnam-si, South Korea) and Hun Kim (Seongnam-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a respiratory syncytial virus (RSV) recombinant fusion protein (F protein) in which a polymerization ...